Radiation oncology firm Elekta has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Monaco 5 radiation therapy treatment planning systems.
The latest version consolidates all of Elekta's treatment planning capabilities into a single system, according to the vendor. Monaco now supports the full spectrum of radiotherapy techniques, including volumetric-modulated arc therapy (VMAT), intensity-modulated radiation therapy (IMRT), and 3D conformal radiation therapy, Elekta said.
Monaco 5 is now available for purchase and use in the U.S.
